GENEVA, July 6 -- PRESTIGE BIOPHARMA IDC CO., LTD filed a patent application (KR2025/017832) for “COMPOSITION FOR IMMUNOHISTOCHEMICAL STAINING OF PAUF PROTEIN COMPRISING ANTI-PAUF MONOCLONAL ANTIBODY AND USE THEREOF”. With publication no. WO/2026/141938, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/577
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....